Drug recall D-0119-2025
Product
Levothyroxine Sodium Tablets USP, 137 mcg, packaged in a) 90-count bottles (NDC 0378-1823-77) and b) 1000-count bottles (NDC 0378-1823-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.
Reason for recall
Superpotent Drug and Subpotent Drug: potency failures obtained
Lots and codes
Lot #: a) 8165919, Exp. Date Dec 2024; 8172050, Exp. Date Mar 2025; 8183251, Exp. Date Sept 2025 b) 3185542, Exp. date Dec 2024; 3192838, Exp. Date Mar 2025; 3208172, Exp. Date Sept 2025
Recall details
- Recalling firm
- Viatris Inc, Canonsburg, PA
- Quantity
- 118,324 bottles
- Distribution
- Nationwide within the United States and Puerto Rico
- Type
- Voluntary: Firm initiated
- Recall initiated
- November 18, 2024
Related products
- Levothyroxine Sodium – drug information
- NDC 0378-1823 Levothyroxine Sodium · Levothyroxine Sodium 137 ug/1 · Mylan Pharmaceuticals Inc.
- NDC 0378-1809 Levothyroxine Sodium · Levothyroxine Sodium 100 ug/1 · Mylan Pharmaceuticals Inc.
- NDC 0378-1805 Levothyroxine Sodium · Levothyroxine Sodium 75 ug/1 · Mylan Pharmaceuticals Inc.
- NDC 0378-1803 Levothyroxine Sodium · Levothyroxine Sodium 50 ug/1 · Mylan Pharmaceuticals Inc.
- NDC 0378-1813 Levothyroxine Sodium · Levothyroxine Sodium 125 ug/1 · Mylan Pharmaceuticals Inc.
- NDC 0378-1819 Levothyroxine Sodium · Levothyroxine Sodium 200 ug/1 · Mylan Pharmaceuticals Inc.
- NDC 0378-1821 Levothyroxine Sodium · Levothyroxine Sodium 300 ug/1 · Mylan Pharmaceuticals Inc.
- NDC 0378-1817 Levothyroxine Sodium · Levothyroxine Sodium 175 ug/1 · Mylan Pharmaceuticals Inc.
- NDC 0378-1811 Levothyroxine Sodium · Levothyroxine Sodium 112 ug/1 · Mylan Pharmaceuticals Inc.
- NDC 0378-1800 Levothyroxine Sodium · Levothyroxine Sodium 25 ug/1 · Mylan Pharmaceuticals Inc.
- NDC 0378-1815 Levothyroxine Sodium · Levothyroxine Sodium 150 ug/1 · Mylan Pharmaceuticals Inc.
- NDC 0378-1807 Levothyroxine Sodium · Levothyroxine Sodium 88 ug/1 · Mylan Pharmaceuticals Inc.